EGFR and non-small cell lung carcinoma: In summary, this work has identified that DRAM1 is a novel regulator of the endocytosis and lysosomal degradation of EGFR through interacting with EPS15 and promoting the assembly of lysosomal v-ATPase in NSCLC cells.